CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

Clinical trial NCT04097444 · UNKNOWN

Trial details

NCT number: NCT04097444
Sponsor: Chugai Pharmaceutical
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2019-10-11
Primary completion: 2022-08-31
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.